Periodic Reporting for period 2 - m-RESIST (Mobile Therapeutic Attention for Patients with Treatment Resistant Schizophrenia)

Approximately 5 million people in the European Union suffer from psychotic disorders. The largest group among them is that of schizophrenic patients, of which between 30-50% can be considered resistant to treatment. Standard intervention in patients with treatment resistant...